Clinical Trials Browser

Completed × Neuroblastoma × Zoledronic Acid × Clear all

NCT00885326 2023-04-10

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00206388 2013-08-02

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

Phase 1 Completed

Neuroblastoma, Recurrence